1. In Vivo
  2. >>Market Access

Expanding The Tent: Improving Trial Participation Among Under-Represented Patient Populations

New Tufts CSDD Research Creates A Baseline For Change

 
• By Ben Comer

The biopharma industry has struggled to recruit patients into clinical trials that adequately reflect the diverse patient populations they hope to reach with new products. Failure to improve minority subgroup participation now will cost trial sponsors later.

IV2003_Clinical-trial-diversity_1168257583_1200.jpg
Inclusive clinical trials are needed to expand evidence development • Source: Shutterstock

The strength and authority of science in society, such as it is, relies on a commonly held belief that scientific findings are objective and impervious to the biases of its practitioners. Scientific facts – including the way human bodies respond to medical interventions – must be recognized and trusted as facts, until new studies and experiments come along to update the old facts or replace them. Identifying and controlling for variables during a clinical study is a key principle of the scientific enterprise, one that distinguishes rigorous and actionable conclusions from studies that distort reality, lead to poor policy decisions, or worse.

All studies have limitations, whether they are acknowledged or not: human biology, including the function of roughly 20% of proteins...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Market Access

More from In Vivo

Rising Leaders 2025: Namrata Saroj On The Importance Of Authenticity In Ophthalmology

 
• By Sushmita Panda

Namrata Saroj, chief business officer of Ocular Therapeutix, is highly respected in the retina community for her contributions to drug development. She talked to In Vivo about her journey in ophthalmology, leadership philosophy and the importance of authenticity in a close-knit specialty.

Johnson & Johnson MedTech: How To Scale Digital Solutions

 
• By Natasha Barrow

J&J's EMEA head of digital solutions, Julia Fishman, talks about the hurdles in scaling digital innovation and what’s up next on J&J’s innovation road map. Robot-assisted surgery pioneer Ivo Broeders gives his perspective on the difficulties in clinical adoption.

Rising Leaders 2025: Emma Hodcroft On Taking Initiative When “Plan A” Falls Short

 
• By Anabel Costa-Ferreira

Emma Hodcroft, co-founder of Pathoplexus and a key Nextstrain contributor, stresses the importance of career flexibility for young scientists. She urges early-stage researchers to embrace curiosity, using her unconventional path as an example of how curiosity can lead to impactful success.